Literature DB >> 24960652

Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.

Mirko Di Capua1, Antonio Coppola1, Assunta Nardo1, Ernesto Cimino1, Matteo N D Di Minno1, Antonella Tufano1, Rosaria Mormile1, Maria L Burzo1, Giovanni Di Minno1, Anna M Cerbone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24960652      PMCID： PMC4385086          DOI： 10.2450/2014.0047-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  22 in total

1.  Acquired haemophilia a in the elderly: case reports.

Authors:  Antonella Tufano; Antonio Coppola; Anna Guida; Ernesto Cimino; Angela Maria De Gregorio; Anna Maria Cerbone; Giovanni Di Minno
Journal:  Curr Gerontol Geriatr Res       Date:  2010-03-03

2.  Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.

Authors:  Peter Collins; Francesco Baudo; Angela Huth-Kühne; Jørgen Ingerslev; Craig M Kessler; Maria E Mingot Castellano; Midori Shima; Jean St-Louis; Hervé Lévesque
Journal:  BMC Res Notes       Date:  2010-06-07

Review 3.  High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review.

Authors:  E Zanon; M Milan; B Brandolin; S Barbar; L Spiezia; G Saggiorato; P Simioni; F Baudo
Journal:  Haemophilia       Date:  2012-10-11       Impact factor: 4.287

4.  pdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease?

Authors:  Giovanni Barillari; Samantha Pasca
Journal:  Transfus Apher Sci       Date:  2012-09-29       Impact factor: 1.764

Review 5.  Acquired haemophilia A: a 2013 update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Thromb Haemost       Date:  2013-09-05       Impact factor: 5.249

6.  Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

Authors:  Francesco Baudo; Francesco de Cataldo; Gianluca Gaidano
Journal:  Haematologica       Date:  2004-06       Impact factor: 9.941

7.  Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.

Authors:  L M Aledort
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

Review 8.  How I manage patients with acquired haemophilia A.

Authors:  Douglas W Sborov; George M Rodgers
Journal:  Br J Haematol       Date:  2013-02-04       Impact factor: 6.998

Review 9.  Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors.

Authors:  Chris Knight; Anne Møller Danø; Tessa Kennedy-Martin
Journal:  Adv Ther       Date:  2009-01-20       Impact factor: 3.845

10.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941
View more
  3 in total

Review 1.  Interventions for treating acute bleeding episodes in people with acquired hemophilia A.

Authors:  Yan Zeng; Ruiqing Zhou; Xin Duan; Dan Long; Songtao Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-08-28

2.  Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases.

Authors:  Makoto Saito; Minoru Kanaya; Koh Izumiyama; Akio Mori; Tatsuro Irie; Masanori Tanaka; Masanobu Morioka; Masahiro Ieko
Journal:  Int J Gen Med       Date:  2016-11-03

3.  Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents.

Authors:  Makoto Saito; Hajime Senjo; Minoru Kanaya; Koh Izumiyama; Akio Mori; Masanori Tanaka; Masanobu Morioka; Masahiro Ieko
Journal:  Hematol Rep       Date:  2018-09-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.